A Budget Impact Model Of The Addition Of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome

Fust, K. (author)

Optum, Boston, MA USA.

Maschio, M. (author)

Optum, Burlington, ON, Canada.

Pastor, M. (author)

Optum, Burlington, ON, Canada.

show more...

Kohli, M. (author)

Optum, Burlington, ON, Canada.

Weinstein, M. C. (author)

Harvard TH Chan Sch Publ Hlth, Boston, MA USA.

Singh, S. (author)

Sunnybrook Res Inst, Toronto, ON, Canada.

Pritchard, M. (author)

Univ Liverpool, Liverpool, Merseyside, England.

Welin, Staffan (author)

Uppsala universitet,Onkologisk endokrinologi

Marteau, R. (author)

Ipsen Pharma, Boulogne, France.

Gabriel, S. (author)

Ipsen Pharma, Boulogne, France.

Feuilly, M. (author)

Ipsen Pharma, Boulogne, France.

show less...

Optum, Boston, MA USA Optum, Burlington, ON, Canada. (creator_code:org_t)

2017

2017

English.

In: Value in Health. - 1098-3015 .- 1524-4733. ; 20:9, s. A548-A549

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)